Molecular epidemiology of hepatitis viruses in Indonesia
印度尼西亚肝炎病毒的分子流行病学
基本信息
- 批准号:11691209
- 负责人:
- 金额:$ 4.74万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Molecular epidemiological analysis was performed on hepatitis C virus (HCV), hepatitis B virus (HBV), hepatitis D virus (HDV) and possible hepatitis virus candidates, GB virus (GBV) and TT virus (TTV), in Surabaya, Indonesia.1. HCV.Mean HCV viremia titers of HCV-1b and HCV-1c were practically the same, and significantly higher than that of HCV-2a. Even among the same subtype, however, HCV viremia titers varied considerably with different HCV isolates. Sequence analysis of HCV revealed that HCV viremia titers were significantly lower when the number of amino acid mutations in the interferon sensitivity determining region (ISDR) of NS5A was four or more, compared with isolates having ISDR mutations of three or less. No other particular mutation (s) was identified in NS5A that correlated well with HCV viremia titers.2. GBV.The prevalence of serum GBV RNA was 2.7% in blood donors, 5.7% in chronic hepatitis patients, 11.5% in liver cirrhosis patients, 7.0% in hepatocellular carcinoma patien … More ts and 29.0% in hemodialysis patients in Surabaya, Indonesia. GBV posicivity was significantly higher in anti-HCV-positive blood donors than in anti-HCV-negative blood donors. No significant correlation was observed between GBV positivity and abnormal liver function tests, suggesting non-hepatopathogenic features of GBV.Phylogenetic analysis identified a novel genotype of GBV (type 5), which represented 40% of total GBV in Surabaya, Indonesia.3. TTV.The prevalence of serum TTV DNA was 33% in blood donors, 22% in chronic hepatitis patients, 24% in liver cirrhosis patients, 46% in hepatocellular carcinoma patients and 44% in hemodialysis patients in Surabaya, Indonesia. Those TTV isolates were phylogenetically classified into Gla, Glb and an as-yet-unclassifiable genotype.4. HBV.All of HBV isolates in Surabaya, Indonesia, were phylogenetically classified into genotype B.5. HDV.HDV was shown to be rather rare in Surabaya, Indonesia, with the prevalence of anti-HDV antibodies being less than 0.5%. Less
对印尼泗水地区的丙型肝炎病毒(丙型肝炎病毒)、乙型肝炎病毒(乙肝病毒)、丁型肝炎病毒(HDV)以及可能的候选肝炎病毒GB病毒(GBV)和TT病毒(TTV)进行了分子流行病学分析。丙型肝炎病毒1b和丙型肝炎病毒1c的平均病毒血症滴度基本相同,显著高于丙型肝炎病毒2a的滴度。然而,即使在相同的亚型中,不同的丙型肝炎病毒分离株的病毒血症滴度也有很大的不同。对丙型肝炎病毒的序列分析显示,当NS5A干扰素敏感决定区(ISDR)的氨基酸突变数为4个或更多时,与ISDR突变为3个或更少的分离株相比,丙型肝炎病毒血症滴度显著降低。未发现NS5A中其他与丙型肝炎病毒病毒血症滴度有很好相关性的特殊突变(S)。献血员血清GBVRNA阳性率为2.7%,慢性肝炎组为5.7%,肝硬化组为11.5%,肝细胞癌组为7.0%印尼苏腊巴亚的血液透析患者中TS和29.0%更多。抗-丙型肝炎病毒阳性献血员的GBV阳性率显著高于抗-丙型肝炎病毒阴性献血员。未发现GBV阳性与肝功能异常试验之间的显著相关性,提示GBV的非肝病特征。系统发育分析发现了一种新的GBV基因型(5型),占印尼泗水地区GBV总数的40%。印尼泗水的献血员、慢性肝炎患者、肝硬变患者、肝细胞癌患者和血液透析患者的血清TTV DNA的患病率分别为33%、22%、24%、46%和44%。TTV分离株在系统发育上分为GLA、GLB型和尚未分类的GLB型。所有印度尼西亚苏腊巴亚的乙肝病毒分离株都被系统发育分类为B.5型。HDV在印度尼西亚的泗水相当罕见,抗HDV抗体的流行率不到0.5%。较少
项目成果
期刊论文数量(37)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
堀田博: "C型肝炎ウイルス非構造タンパク質NS5Aによるインターフェロン抗ウイルス活性の抑制"臨床成人病. 30(10). 100-102 (2000)
Hiroshi Hotta:“丙型肝炎病毒非结构蛋白 NS5A 抑制干扰素抗病毒活性”《临床成人疾病》30(10)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sakugawa,Hiroshi: "Novel variats of Heaptitis Delta virus genotype II predominantes in an endemic area,Okinawa,Japan"J.Med.Virol.. 58(4). 366-372 (1999)
Sakukawa, Hiroshi:“日本冲绳流行区中 Delta 型肝炎病毒基因型 II 的新变种占主导地位”J.Med.Virol.. 58(4)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Wang, Fan: "Complex formation between hepatitis C virus core protein and p2lWaf1/Cip1/Sdi1."Biochem.Biophys.Res.Commun.. 273(2). 479-484 (2000)
王帆:“丙型肝炎病毒核心蛋白与p2lWaf1/Cip1/Sdi1之间的复合物形成”。Biochem.Biophys.Res.Commun. 273(2)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Apichartpiyakul,C: "Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in Northem/Northeastem Thailand."Jpn.J.Infect.Dis. 52(1). 121-123 (1999)
Apichartpiyakul,C:“泰国北部/东北部献血者和静脉注射毒品使用者中丙型肝炎病毒的血清流行率和亚型分布。”Jpn.J.Infect.Dis。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ishido,Satoshi: "Methods in Molecular Medicine"Possible involvement of the NS3 protein of hepatitis C virus in hepatocarcinogenesis : its interaction with the p53 tumor suppressor.. 37-55 (2000)
Ishido,Satoshi:“分子医学方法”丙型肝炎病毒 NS3 蛋白在肝癌发生中的可能参与:其与 p53 肿瘤抑制因子的相互作用.. 37-55 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOTTA Hak其他文献
HOTTA Hak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOTTA Hak', 18)}}的其他基金
Study on molecular mechanisms of glucose metabolic disorders mediated by hepatitis C virus
丙型肝炎病毒介导的糖代谢紊乱的分子机制研究
- 批准号:
24590976 - 财政年份:2012
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on possible correlation between carcinogenic risk and genetic variation of hepatitis B and C viruses in Indonesia.
印度尼西亚乙型和丙型肝炎病毒致癌风险与遗传变异之间可能相关性的研究。
- 批准号:
16406015 - 财政年份:2004
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Viral factors that determine viremia titers of hepatitis C virus in Indonesia
决定印度尼西亚丙型肝炎病毒病毒血症滴度的病毒因素
- 批准号:
13576015 - 财政年份:2001
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular epidemiology of hepatitis viruses in Indonesia
印度尼西亚肝炎病毒的分子流行病学
- 批准号:
10041196 - 财政年份:1998
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for international Scientific Research
Inhibition of apoptosis by the NS3 protein of hepatitis C virus and its interaction with the p53 tumor suppressor protein.
丙型肝炎病毒 NS3 蛋白对细胞凋亡的抑制及其与 p53 肿瘤抑制蛋白的相互作用。
- 批准号:
09670317 - 财政年份:1997
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on hepatitis C virus new genotypes in Southeast Asia
东南亚丙型肝炎病毒新基因型研究
- 批准号:
08041176 - 财政年份:1996
- 资助金额:
$ 4.74万 - 项目类别:
Grant-in-Aid for international Scientific Research
相似海外基金
The 13th Canadian Symposium on Hepatitis C Virus (CSHCV)
第13届加拿大丙型肝炎病毒研讨会(CSHCV)
- 批准号:
487828 - 财政年份:2023
- 资助金额:
$ 4.74万 - 项目类别:
Miscellaneous Programs
Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒 (HCV) 感染受控人类感染模型 (CHIM) 关键方面的表征
- 批准号:
478700 - 财政年份:2023
- 资助金额:
$ 4.74万 - 项目类别:
Operating Grants
After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
治愈之后:衡量直接作用抗病毒药物对加拿大艾滋病毒/丙型肝炎病毒合并感染者的全面影响
- 批准号:
469805 - 财政年份:2022
- 资助金额:
$ 4.74万 - 项目类别:
Operating Grants
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
- 批准号:
10449670 - 财政年份:2022
- 资助金额:
$ 4.74万 - 项目类别:
A Simple at-home test for rapid and accurate screening for Hepatitis C Virus (HCV) exposure
简单的家庭测试,可快速、准确地筛查丙型肝炎病毒 (HCV) 暴露
- 批准号:
10709130 - 财政年份:2022
- 资助金额:
$ 4.74万 - 项目类别:
Workshop for the development of a Controlled Human Infection Model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒(HCV)感染的受控人类感染模型(CHIM)开发研讨会
- 批准号:
460792 - 财政年份:2022
- 资助金额:
$ 4.74万 - 项目类别:
Miscellaneous Programs
Rapid, Point-of-Care Diagnostics for Hepatitis C Virus
丙型肝炎病毒的快速护理点诊断
- 批准号:
10683045 - 财政年份:2022
- 资助金额:
$ 4.74万 - 项目类别:
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
- 批准号:
10620846 - 财政年份:2022
- 资助金额:
$ 4.74万 - 项目类别:
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)
直接作用抗病毒药物预防丙型肝炎病毒感染供者肾移植至未感染受者的随机对照试验 (PREVENT-HCV)
- 批准号:
10597168 - 财政年份:2022
- 资助金额:
$ 4.74万 - 项目类别:
The effect of opioids, stimulants, and the simultaneous use of both on the hepatitis C virus (HCV) cascade of care in rural communities in the United States
阿片类药物、兴奋剂以及同时使用两者对美国农村社区丙型肝炎病毒 (HCV) 级联护理的影响
- 批准号:
10459753 - 财政年份:2022
- 资助金额:
$ 4.74万 - 项目类别:














{{item.name}}会员




